Key result
Post-COVID dyspnea persists long-term, driven by cardiovascular pathology, lung damage, hyperventilation, and deconditioning.
Why the study?
Post-COVID-19 shortness of breath is a common manifestation that can persist for months or years and reduce quality of life.
Post-COVID-19 dyspnea is a multifactorial condition requiring a multidisciplinary approach to differentiate between structural organ damage and functional impairments.
May warrant multidisciplinary evaluation of persistent post-COVID dyspnea; leaves open dominant mechanisms for targeted prospective studies.
New coronavirus infection may lead to long-term consequences, particularly to post-COVID syndrome, one of the most common manifestations of which is dyspnea. Post-COVID-19 shortness of breath may persist from one to several months and even years that results in low quality of life of patients. The review highlights possible risk factors and causes of dyspnea in post-COVID period such as lung damage, cardiovascular pathology, hyperventilation syndrome, dysfunction of the autonomic nervous system, detraining, anemia, etc. The authors present data about COVID-19-associated causes of dyspnea and severity of acute COVID-19. The review emphasizes the importance of a multidisciplinary approach to the diagnosis and treatment of patients with shortness of breath in post-COVID-19 period.
No takes yet. Share an insight, caveat, or question.
Подзолков et al. (2024) conducted a review in Post-COVID-19 syndrome with dyspnea. COVID-19 was evaluated. Dyspnea is a common manifestation of post-COVID syndrome that can persist for months or years, driven by multiple factors including lung damage, cardiovascular pathology, hyperventilation, and deconditioning.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: